Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
13,080,549
-
Total 13F shares
-
78,976
-
Share change
-
-8,402,769
-
Total reported value
-
$38,714
-
Price per share
-
$0.50
-
Number of holders
-
9
-
Value change
-
-$31,377,862
-
Number of buys
-
2
-
Number of sells
-
56
Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) as of Q4 2024
As of 31 Dec 2024,
EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
78,976 shares.
The largest 9 holders included
XTX Topco Ltd, SIMPLEX TRADING, LLC, BARCLAYS PLC, Stanley-Laman Group, Ltd., ACADIAN ASSET MANAGEMENT LLC, Russell Investments Group, Ltd., Archer Investment Corp, Credit Agricole S A, and Farther Finance Advisors, LLC.
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.